These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 79664)

  • 1. Structure of Clostridium botulinum type B derivative toxin: inhibition with a fragment of toxin from binding to synaptosomal fraction [proceedings].
    Kozaki S; Miyazaki S; Sakaguchi G
    Jpn J Med Sci Biol; 1978 Apr; 31(2):163-6. PubMed ID: 79664
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of botulinum type A, B and E derivative toxins with synaptosomes of rat brain.
    Kozaki S
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jul; 308(1):67-70. PubMed ID: 492355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of Clostridium botulinum type C neurotoxin to rat brain synaptosomes.
    Agui T; Syuto B; Oguma K; Iida H; Kubo S
    J Biochem; 1983 Aug; 94(2):521-7. PubMed ID: 6630172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Clostridium botulinum toxins type D and C1 in molecular property, antigenicity and binding ability to rat-brain synaptosomes.
    Murayama S; Syuto B; Oguma K; Iida H; Kubo S
    Eur J Biochem; 1984 Aug; 142(3):487-92. PubMed ID: 6468375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin.
    Kozaki S; Kamata Y; Nagai T; Ogasawara J; Sakaguchi G
    Infect Immun; 1986 Jun; 52(3):786-91. PubMed ID: 2423459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding to mouse brain synaptosomes of Clostridium botulinum type E derivative toxin before and after tryptic activation.
    Kozaki S; Sakaguchi G
    Toxicon; 1982; 20(5):841-6. PubMed ID: 7179292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological characterization of papain-induced fragments of Clostridium botulinum type A neurotoxin and interaction of the fragments with brain synaptosomes.
    Kozaki S; Miki A; Kamata Y; Ogasawara J; Sakaguchi G
    Infect Immun; 1989 Sep; 57(9):2634-9. PubMed ID: 2668181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
    Blasi J; Chapman ER; Link E; Binz T; Yamasaki S; De Camilli P; Südhof TC; Niemann H; Jahn R
    Nature; 1993 Sep; 365(6442):160-3. PubMed ID: 8103915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding ability of Clostridium botulinum neurotoxin to the synaptosome upon treatment of various kinds of the enzymes.
    Kitamura M; Sone S
    Biochem Biophys Res Commun; 1987 Mar; 143(3):928-33. PubMed ID: 3566763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the ADP-ribosylation of actin by Clostridium botulinum C2 toxin and Clostridium perfringens iota toxin.
    Aktories K; Geipel U; Wille M; Just I
    J Physiol (Paris); 1990; 84(4):262-6. PubMed ID: 2079662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
    Han S; Arvai AS; Clancy SB; Tainer JA
    J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Binding and degenerative effect of Clostridium botulinum type A, C and E toxins on cultured neurons].
    Kurokawa Y
    Hokkaido Igaku Zasshi; 1987 May; 62(3):381-91. PubMed ID: 3610033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of botulinum type Cl, D and E neurotoxins to neuronal cell lines and synaptosomes.
    Yokosawa N; Tsuzuki K; Syuto B; Fujii N; Kimura K; Oguma K
    Toxicon; 1991; 29(2):261-4. PubMed ID: 2048142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: Antigenicities of two fragments of Clostridium botulinum type B derivative toxin.
    Kozaki S; Sakaguchi G
    Jpn J Med Sci Biol; 1975; 28(5-6):323-6. PubMed ID: 1228241
    [No Abstract]   [Full Text] [Related]  

  • 16. [Toxoids of botulinum toxin type G].
    Puig de Centorbi ON; Ciccarelli AS; Giménez DF
    Rev Argent Microbiol; 1980; 12(1):10-7. PubMed ID: 6755549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the immunological heterogeneity of Clostridium botulinum B type toxin.
    Rymkiewicz D; Sawicki J; Brühl A
    Arch Immunol Ther Exp (Warsz); 1979; 27(5):709-14. PubMed ID: 398207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of RNA species in the RNA-toxin complex and structure of the complex in Clostridium botulinum type E.
    Kitamura M
    Biochem Biophys Res Commun; 2002 Feb; 291(1):154-7. PubMed ID: 11829476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodination of botulinum neurotoxin type A with retention of biological activity and its binding to brain synaptosomes.
    Williams RS; Tse CK; Dolly JO; Hambleton P; Melling J
    Eur J Biochem; 1983 Mar; 131(2):437-45. PubMed ID: 6339240
    [No Abstract]   [Full Text] [Related]  

  • 20. Absorption of botulinum type B progenitor and derivative toxins through the intestine [proceedings].
    Ohishi I; Sugii S; Sakaguchi G
    Jpn J Med Sci Biol; 1978 Apr; 31(2):161-3. PubMed ID: 682373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.